Cargando…
Developing-country vaccine manufacturers’ technical capabilities can make a difference in global immunization
Members of the Developing Countries Vaccine Manufacturers’ Network (DCVMN) have been actively engaged in the development of COVID-19 vaccine candidates. According to the WHO COVID-19 vaccine landscape updated on 29 December 2020, 18 member manufacturers had vaccines in preclinical or clinical trials...
Autores principales: | Hayman, Benoit, Dennehy, Maureen |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Ltd.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8330991/ https://www.ncbi.nlm.nih.gov/pubmed/34362602 http://dx.doi.org/10.1016/j.vaccine.2021.07.044 |
Ejemplares similares
-
Two decades of vaccine innovations for global public good: Report of the Developing Countries’ Vaccine Manufacturers Network 20th meeting, 21–23 october 2019, Rio de Janeiro, Brazil
por: Pagliusi, Sonia, et al.
Publicado: (2020) -
Advancing innovation for vaccine manufacturers from developing countries: Prioritization, barriers, opportunities
por: Hayman, Benoit, et al.
Publicado: (2021) -
Emerging vaccine manufacturers are innovating for the next decade
por: Hayman, Benoit, et al.
Publicado: (2020) -
Expanding global vaccine manufacturing capacity: Strategic prioritization in small countries
por: Mukherjee, Sanjana, et al.
Publicado: (2023) -
Strengthening vaccines and medicines manufacturing capabilities in Africa: challenges and perspectives
por: Saied, AbdulRahman A, et al.
Publicado: (2022)